Liothyronine sodium
NDC 16714-168, Liothyronine sodium, tablet, from Northstar Rx LLC.
- Product NDC
- 16714-168
- Status
- Listed
- Labeler
- Northstar Rx LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214803
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16714-168 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM50 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16714-168-01 | 16714016801 | 100 TABLET in 1 BOTTLE (16714-168-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c97dc9ec-af73-4836-aa0d-c27e66e792a9NADAC price for package 16714016801
GET /v1/drugs/nadac/16714016801
Use it
Look up 16714-168 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16714-168 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16714-168. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.